Literature DB >> 6708126

Opsonization of pneumococci by whole serum from sickle cell disease patients.

E F Bloch, O Castro, J E Gregory, C Okoh.   

Abstract

An in vitro opsonic activity test was developed to measure the ability of whole serum from sickle cell disease patients to enhance the phagocytosis of Streptococcus pneumoniae by normal white blood cells. At the 30- and 60-minute incubation time periods, there was a 2- to 3-log reduction in the number of colonyforming units of S pneumoniae with both normal and sickle cell serum indicating opsonization of the organisms. However, the reduction in colony-forming units was significantly greater with normal than with sickle cell serum at both time periods (P <.0005 and P <.025 for the 30- and 60-minute time intervals, respectively). The sickle cell sera used in this assay were obtained from pediatric patients (age range, 1 to 15 years) and from adults (age range, 16 to 30 years). Based on this assay, sera from the adult sickle cell patients had a lower mean opsonic activity than that of the pediatric group. The significance of the lower opsonic activity in the adults with sickle cell disease is unknown and requires additional investigation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708126      PMCID: PMC2561746     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  11 in total

1.  Effect of antibody upon clearance of I-125-labelled pneumococci by the spleen and liver.

Authors:  M L Schulkind; E F Ellis; R T Smith
Journal:  Pediatr Res       Date:  1967-05       Impact factor: 3.756

2.  Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine.

Authors:  S W Hosea; C G Burch; E J Brown; R A Berg; M M Frank
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

3.  Alternative complement pathway activity in sera from patients with sickle cell disease.

Authors:  S M Koethe; J T Casper; G E Rodey
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

4.  RES phagocytosis in beta-thalassemia and sickle cell anemia.

Authors:  G Drivas; J Kafezas; A Kalos; G Theodoropoulos; K Melissinos
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

5.  An abnormality of the alternate pathway of complement activation in sickle-cell disease.

Authors:  R B Johnston; S L Newman; A G Struth
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

6.  Metabolic activity of polymorphonuclear leukocytes in sickle cell anemia.

Authors:  N V Dimitrov; F R Douwes; B Bartolotta; S Nochumson; M A Toth
Journal:  Acta Haematol       Date:  1972       Impact factor: 2.195

Review 7.  Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature.

Authors:  E Barrett-Connor
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

8.  Distribution of T and B lymphocytes in lymphoid tissue of infants and children.

Authors:  J B Neiburger; R G Neiburger; S T Richardson; J L Grosfeld; R L Baehner
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  Decreased opsonization for Streptococcus pneumoniae in sickle cell disease: studies on selected complement components and immunoglobulins.

Authors:  A B Bjornson; M H Gaston; C L Zellner
Journal:  J Pediatr       Date:  1977-09       Impact factor: 4.406

10.  OBSERVATIONS ON THE SITES OF REMOVAL OF BACTERIA FROM THE BLOOD IN PATIENTS WITH BACTERIAL ENDOCARDITIS.

Authors:  P B Beeson; E S Brannon; J V Warren
Journal:  J Exp Med       Date:  1945-01-01       Impact factor: 14.307

View more
  1 in total

1.  Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.

Authors:  A B Bjornson; J S Lobel
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.